Biomedical “hot†scientific instruments help development
In recent years, China's biopharmaceutical market has been rising, and the innovative power brought by new drug research and development has brought unprecedented opportunities for development in the biopharmaceutical industry. On the one hand, the domestic pharmaceutical bio-health business incubation has attracted much attention from the capital market in recent years and has become a hot investment field for PE/VC. On the other hand, the Chinese government has vigorously promoted the research and development of bio-innovative drugs, and has no plans or support policies. Exceptions involve the development of innovative medicines, major and multi-drug medications. With the vigorous development of the bio-pharmaceutical industry, it will surely be a huge business opportunity for biopharmaceutical scientific instruments.
From research and development to production, scientific instruments help every step of biopharmaceutical development
It is well known that biopharmaceuticals are a very long and complex process from research and development to production. Research and development includes target discovery, screening of antibody libraries, antibody glycoform analysis and cell line development; production includes upstream biological reactions and downstream separation. Purification; quality control runs through the entire process from biodevelopment to production.
The discovery of new biopharmaceuticals stems from the study of the mechanisms behind life phenomena, and it is therefore necessary to clarify the complex relationships between biomolecules. Biomacromolecule interaction techniques are evolving from labeling, lossy to non-marking, and lossless. PALL's exclusive Biofilm Interference Technology (BLI) has evolved into the world's fastest growing label-free detection technology, providing real-time, unlabeled molecular interaction and content detection information, not only for a wide range of applications. Early research and development, screening and identification, preclinical and clinical research, and downstream production quality control, as well as deep and unique applications in basic research in life sciences, biopharmaceutical development, food safety, etc., have won wide recognition.
PCR technology plays an indispensable role in the screening of antibody drugs. With the rapid development of antibody drugs in China, PCR instruments are also welcoming new opportunities for development. According to BBCRESERCH, the global gene sequencing market has grown from 794 million US dollars in 2007 to 4.5 billion US dollars in 2013, with a compound annual growth rate of 33.5%. It is expected to reach 11.7 billion US dollars in 2018, with a compound annual growth rate of 21.1%. . In addition, the gap between domestically produced instruments and imported instruments has become smaller and smaller in recent years. In the future, localization and automation of this market will be the general trend.
Corn Starch ,Corn Starch Heb,Bulk Corn Starch,Cornstarch Healthy
Shanghai J.Shine Co.,Ltd , https://www.jshinechem.com